Keywords: uk, nice, clears, roche, mabthera, maintenance, therapy

UK's NICE clears Roche's MabThera as maintenance therapy for NHL

Article | 03 March 2008

Print This

The UK's National Institute for Health and Clinical Excellence has issued final guidance recommending the use of Swiss drug major ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in